Literature DB >> 28029397

Matrin 3 variants are frequent in Italian ALS patients.

Giuseppe Marangi1, Serena Lattante1, Paolo Niccolò Doronzio1, Amelia Conte2, Giorgio Tasca3, Mauro Monforte4, Agata Katia Patanella2, Giulia Bisogni2, Emiliana Meleo2, Salvatore La Spada5, Marcella Zollino1, Mario Sabatelli6.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by loss of motor neurons in the primary motor cortex, brainstem, and spinal cord. Recently, missense variants in MATR3 were identified in familial and sporadic ALS patients, but very few additional ALS patients have been reported so far. The p.S85C MATR3 variant was previously associated to a different phenotype, namely a distal myopathy associated with dysphagia and dysphonia. Here, we assessed the contribution of MATR3 variants in a cohort of 322 Italian ALS patients. We identified 5 different missense MATR3 variants (p.Q66K, p.G153C, p.E664A, p.S707L, and p.N787S) in 6 patients (1.9%). None of our patients showed signs of myopathy at electrophysiological examination. Muscle biopsy, performed in 2 patients, showed neurogenic changes and normal nuclear staining with anti-matrin 3 antibody. Our results confirm that MATR3 variants are associated with ALS and suggest that they are more frequent in Italian ALS patients. Further studies are needed to elucidate the pathogenic significance of identified variants in sporadic and familial ALS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Distal myopathy; Matrin 3; Targeted NGS sequencing

Mesh:

Substances:

Year:  2016        PMID: 28029397     DOI: 10.1016/j.neurobiolaging.2016.09.023

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients.

Authors:  Priyam Narain; Aditya K Padhi; Upma Dave; Dibyakanti Mishra; Rohit Bhatia; Perumal Vivekanandan; James Gomes
Journal:  Neurogenetics       Date:  2019-08-20       Impact factor: 2.660

Review 2.  Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications.

Authors:  Ruth Chia; Adriano Chiò; Bryan J Traynor
Journal:  Lancet Neurol       Date:  2017-11-16       Impact factor: 44.182

3.  The NGS technology for the identification of genes associated with the ALS. A systematic review.

Authors:  Valentina Pecoraro; Jessica Mandrioli; Chiara Carone; Adriano Chiò; Bryan J Traynor; Tommaso Trenti
Journal:  Eur J Clin Invest       Date:  2020-05-19       Impact factor: 5.722

Review 4.  RNA-Binding Proteins in Amyotrophic Lateral Sclerosis.

Authors:  Melody Zhao; Jihye Rachel Kim; Rebekah van Bruggen; Jeehye Park
Journal:  Mol Cells       Date:  2018-08-29       Impact factor: 5.034

5.  N-terminal sequences in matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements.

Authors:  M Carolina Gallego-Iradi; Haley Strunk; Anthony M Crown; Rachel Davila; Hilda Brown; Edgardo Rodriguez-Lebron; David R Borchelt
Journal:  Lab Invest       Date:  2019-04-24       Impact factor: 5.662

Review 6.  Linking hnRNP Function to ALS and FTD Pathology.

Authors:  Maria D Purice; J Paul Taylor
Journal:  Front Neurosci       Date:  2018-05-15       Impact factor: 4.677

7.  ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.

Authors:  Ashley Boehringer; Krystine Garcia-Mansfield; Gurkaran Singh; Nadine Bakkar; Patrick Pirrotte; Robert Bowser
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

8.  Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization.

Authors:  Ahmed M Malik; Roberto A Miguez; Xingli Li; Ye-Shih Ho; Eva L Feldman; Sami J Barmada
Journal:  Elife       Date:  2018-07-17       Impact factor: 8.140

9.  RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3.

Authors:  Nandini Ramesh; Elizabeth L Daley; Amanda M Gleixner; Jacob R Mann; Sukhleen Kour; Darilang Mawrie; Eric N Anderson; Julia Kofler; Christopher J Donnelly; Evangelos Kiskinis; Udai Bhan Pandey
Journal:  Acta Neuropathol Commun       Date:  2020-10-31       Impact factor: 7.801

10.  RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.

Authors:  Nandini Ramesh; Sukhleen Kour; Eric N Anderson; Dhivyaa Rajasundaram; Udai Bhan Pandey
Journal:  Acta Neuropathol Commun       Date:  2020-08-18       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.